Başaran, G. ., Twelves, C. ., , Cortés, J. ., & Awada, A. . (2017). Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer. Cancer Treatment Reviews, 63, 144-155. https://doi.org/10.1016/j.ctrv.2017.12.002 (Original work published 2017)

Turner, N. ., Finn, R. ., Martin, M. ., Im, S. ., DeMichele, A. ., Ettl, J. ., … Gelmon, K. . (2018). Clinical Considerations of the Role of Palbociclib in the Management of Advanced Breast Cancer Patients With and Without Visceral Metastases. Annals of Oncology : Official Journal of the European Society for Medical Oncology. https://doi.org/10.1093/annonc/mdx797 (Original work published 2018)

Schneeweiss, A. ., Park-Simon, T. ., Albanell, J. ., Lassen, U. ., Cortés, J. ., , … Cervantes, A. . (2018). Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer. Investigational New Drugs. https://doi.org/10.1007/s10637-018-0562-4 (Original work published 2018)